Niraj K. Shenoy
Experienced in Myelodysplastic Syndrome (MDS)

Dr. Niraj K. Shenoy

Hematology | Oncology
Northwestern Medical Group
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
16 Years of Experience

Experienced in Myelodysplastic Syndrome (MDS)
Northwestern Medical Group
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Niraj Shenoy is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Shenoy has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, and Nephrectomy.

His clinical research consists of co-authoring 41 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Myelodysplastic Syndrome (MDS).

Graduate Institution
Bangalore Medical College, 2010.0
Residency
Jacobi Medical Center/Albert Einstein College of Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine - Hematology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Palos Community Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

675 N St Clair St Ste 20-150, Galter Pavilion, Chicago, IL 60611
Call: 833-776-5759

Additional Areas of Focus

Dr. Shenoy has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Bladder Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer
A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer
Enrollment Status: Recruiting
Publish Date: October 17, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Erlotinib
Study Phase: Phase 2

41 Total Publications

Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion.
Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
View All 41 Publications
Similar Doctors
Elite in Myelodysplastic Syndrome (MDS)
Dr. Lucy A. Godley
Hematology | Oncology
Elite in Myelodysplastic Syndrome (MDS)
Dr. Lucy A. Godley
Hematology | Oncology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (0.1 miles away)
866-587-4322
Experience:
29+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lucy Godley is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Godley has been practicing medicine for over 29 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are RUNX1 Familial Platelet Disorder, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Elite in Myelodysplastic Syndrome (MDS)
Dr. Olatoyosi M. Odenike
Hematology Oncology | Hematology | Oncology
Elite in Myelodysplastic Syndrome (MDS)
Dr. Olatoyosi M. Odenike
Hematology Oncology | Hematology | Oncology

The University Of Chicago

5758 S Maryland Ave, 
Chicago, IL 
 (7.3 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Olatoyosi Odenike is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Odenike is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Odenike is currently accepting new patients.

Distinguished in Myelodysplastic Syndrome (MDS)
Dr. Jessica K. Altman
Hematology | Oncology
Distinguished in Myelodysplastic Syndrome (MDS)
Dr. Jessica K. Altman
Hematology | Oncology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (0.1 miles away)
866-587-4322
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jessica Altman is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Altman has been practicing medicine for over 25 years and is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

VIEW MORE MYELODYSPLASTIC SYNDROME (MDS) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shenoy's expertise for a condition
ConditionClose
      • Advanced
      • Renal Cell Carcinoma (RCC)
        Dr. Shenoy is
        Advanced
        . Learn about Renal Cell Carcinoma (RCC).
        See more Renal Cell Carcinoma (RCC) experts
      • Experienced
      • Adult Soft Tissue Sarcoma
        Dr. Shenoy is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Cholangiocarcinoma (Bile Duct Cancer)
        Dr. Shenoy is
        Experienced
        . Learn about Cholangiocarcinoma (Bile Duct Cancer).
        See more Cholangiocarcinoma (Bile Duct Cancer) experts
      • Chromophobe Renal Cell Carcinoma
        Dr. Shenoy is
        Experienced
        . Learn about Chromophobe Renal Cell Carcinoma.
        See more Chromophobe Renal Cell Carcinoma experts
      • Clear Cell Sarcoma
        Dr. Shenoy is
        Experienced
        . Learn about Clear Cell Sarcoma.
        See more Clear Cell Sarcoma experts
      • Ewing Sarcoma
        Dr. Shenoy is
        Experienced
        . Learn about Ewing Sarcoma.
        See more Ewing Sarcoma experts
      • Familial Prostate Cancer
        Dr. Shenoy is
        Experienced
        . Learn about Familial Prostate Cancer.
        See more Familial Prostate Cancer experts
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.